Seed VC · UK
The convergence of biology and AI is healthcare's defining opportunity. Bio-AI ventures are reshaping diagnostics, therapeutics, and delivery—making medicine faster, cheaper, and more precise.
Business models
deeptech_ip, biotech_therapeutics, platform
Customer segments
Pharma, CROs, Hospitals, Payers, Patients
Geography
UK, US, MEA
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Panacea Stars writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Panacea Stars alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Panacea Stars is one of them, and we'll tell you exactly where they sit in your top 100.